首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Alteration of Th17 and Foxp3+ regulatory T cells in patients with unexplained recurrent spontaneous abortion before and after the therapy of hCG combined with immunoglobulin
【2h】

Alteration of Th17 and Foxp3+ regulatory T cells in patients with unexplained recurrent spontaneous abortion before and after the therapy of hCG combined with immunoglobulin

机译:hCG联合免疫球蛋白治疗前后无法解释的反复自然流产患者Th17和Foxp3 +调节性T细胞的变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We conducted this study to investigate the effects of the combination therapy of human chorionic gonadotropin (hCG) plus immunoglobulin (IG) on the levels of T helper 17 (Th17) cells and Foxp3+ regulatory T cells (Treg) in patients with unexplained recurrent spontaneous abortion (URSA). Twenty pregnant women with URSA underwent combination therapy of hCG plus IG. Flow cytometry was performed to measure the proportions of Th17 and Treg cells before and after treatment. RT-PCR and ELISA were applied to detect the concentrations of interleukin (IL)-17, IL-6, IL-10, and transforming growth factor (TGF)-β1 in the peripheral blood. The therapy of hCG combined with IG may induce a decrease in the Th17/Treg ratio and the Treg bias, which may be beneficial for the maintenance of pregnancy. The levels of Th17 cells and related cytokines IL-17 and IL-6 decreased after the treatment (P<0.05). At the same time, levels of Treg cells and the related cytokines IL-10 and TGF-β1 increased (P<0.05). The Th17/Treg ratio decreased significantly after treatment. In conclusion, the occurrence of URSA may be associated with the Th17/Treg balance disorder, and correcting the disorder may be one of the mechanisms behind the efficacy of combination therapy for URSA.
机译:我们进行了这项研究,以研究人绒毛膜促性腺激素(hCG)和免疫球蛋白(IG)联合治疗对T辅助细胞17(Th17)和Foxp3 + 调节性T细胞(Treg)的影响。 )无法解释的反复自然流产(URSA)的患者。 20名URSA孕妇接受了hCG加IG联合治疗。进行流式细胞术以测量治疗前后Th17和Treg细胞的比例。应用RT-PCR和ELISA检测外周血中白介素(IL)-17,IL-6,IL-10和转化生长因子(TGF)-β1的浓度。 hCG联合IG治疗可能会导致Th17 / Treg比值和Treg偏倚的降低,这可能对维持妊娠有益。治疗后Th17细胞及相关细胞因子IL-17和IL-6水平下降(P <0.05)。同时,Treg细胞及相关细胞因子IL-10和TGF-β1水平升高(P <0.05)。治疗后Th17 / Treg比值显着下降。总之,URSA的发生可能与Th17 / Treg平衡障碍有关,纠正该障碍可能是URSA联合疗法疗效背后的机制之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号